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Abstract
 
The specificity of CD8
 
 
 
 T cell responses can vary dramatically between primary and secondary
infections. For example, NP
 
366–374
 
/D
 
b
 
- and PA
 
224–233
 
/D
 
b
 
-specific CD8
 
 
 
 T cells respond in
approximately equal numbers to a primary influenza virus infection in C57BL/6 mice, whereas
NP
 
366–374
 
/D
 
b
 
-specific CD8
 
 
 
 T cells dominate the secondary response. To investigate the
mechanisms underlying this changing pattern of immunodominance, we analyzed the role of
antigen presentation in regulating the specificity of the T cell response. The data show that
both dendritic and nondendritic cells are able to present the NP
 
366–374
 
/D
 
b
 
 epitope, whereas
only dendritic cells effectively present the PA
 
224–233
 
/D
 
b
 
 epitope after influenza virus infection,
both in vitro and in vivo. This difference in epitope expression favored the activation and ex-
pansion of NP
 
366–374
 
/D
 
b
 
-specific CD8
 
 
 
 memory T cells during secondary infection. The data
also show that the immune response to influenza virus infection may involve T cells specific for
epitopes, such as PA
 
224–233
 
/D
 
b
 
, that are poorly expressed at the site of infection. In this regard,
vaccination with the PA
 
224–233
 
 peptide actually had a detrimental effect on the clearance of a
subsequent influenza virus infection. Thus, differential antigen presentation impacts both the
specificity of the T cell response and the efficacy of peptide-based vaccination strategies.
Key words: antigen-presenting cells • antigen presentation • CD8-positive T lymphocytes • 
inﬂuenza • immunologic memory
 
Introduction
 
The CD8
 
 
 
 T cell responses to respiratory virus infections
tend to be highly focused in terms of antigen specificity (1).
In the case of influenza virus infection of mice, CD8
 
 
 
 T
cell responses are typically directed at only a handful of spe-
cific epitopes. And in a particularly extreme example, the
entire CD8
 
 
 
 T cell response to a mouse parainfluenza virus
(Sendai virus) is directed at a single epitope (2, 3). The
 
highly focused nature of CD8
 
 
 
 T cell responses to patho-
gens indicates that individual epitopes differ in their capacity
to induce T cell responses (4). Indeed, depending on their
relative contributions to the total T cell response, individual
 
epitopes can be classified as dominant, codominant, or
subdominant, thereby establishing an immunodominance
hierarchy. Interestingly, the immunodominance status of
any given epitope is generally only a relative, rather than in-
trinsic, characteristic. Thus, elimination of a dominant
epitope from a pathogen usually results in the elevation of a
previously subdominant epitope to a dominant status (4, 5).
Such a switch in T cell specificity does not necessarily affect
the magnitude of the total CD8 T cell response, suggesting
that epitope immundominance does not directly regulate
the extent of T cell expansion.
Understanding immunodominance patterns is critical for
the development of effective vaccines designed to promote
cellular immunity. Therefore, substantial effort has been di-
rected at identifying dominant epitopes and understanding
the mechanisms that regulate dominance hierarchies. These
studies have identified several factors that appear to deter-
mine the immunodominance hierarchy of MHC class
I–restricted epitopes. The most important factor appears to
be the density of antigen that is effectively presented on an-
tigen-presenting cells. Antigen density is controlled by the
relative efficiency of distinct antigen processing steps such
as route of antigen acquisition, protease/proteosome degra-
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Impact of Differential Antigen Processing on CD8
 
 
 
 T Cells
 
dation, transport into the endoplasmic reticulum and the
affinity of the peptide for class I molecules (or its ability to
form stable peptide/class I complexes; references 5–12).
The complexity of the T cell repertoire also influences im-
munodominance and epitope selection in the course of an
infection (13). Thus, some epitopes may be subdominant if
the number of T cells available to respond to that epitope is
especially low.
Recently, it has been shown that T cell immunodomi-
nance patterns can differ substantially between primary and
secondary responses to infection (14–16). For example,
Belz et al. (15) have demonstrated a substantial shift in the
relative contributions of T cells specific for two major
epitopes, nucleoprotein (NP
 
366–374
 
/D
 
b
 
) and acidic polymer-
ase (PA
 
224–233
 
/D
 
b
 
), between the primary and secondary re-
sponse in influenza virus–infected C57BL/6 mice. Whereas
T cells specific for both of these epitopes are present in
equivalent numbers in the lung during the primary re-
sponse to influenza virus infection, T cells specific for the
NP
 
366–374
 
/D
 
b
 
 epitope dominate the secondary response (15,
16). In this report, we investigated the mechanism underly-
ing this changing pattern of immunodominance after influ-
enza virus infection. The data show that the NP
 
366–374
 
/D
 
b
 
and PA
 
224–233
 
/D
 
b
 
 epitopes of influenza virus are differen-
tially processed by dendritic and nondendritic cells and that
this difference in epitope expression favors the expansion of
NP
 
366–374
 
/D
 
b
 
 specific memory CD8
 
 
 
 T cells during sec-
ondary infection.
 
Materials and Methods
 
Viruses, Animals, and Infections.
 
The Enders strain of Sendai
virus and influenza virus A/HK-x31 (x31, H3N2) and A/PR8/
34 (PR8, H1N1) were grown, stored, and titrated as described
previously (13, 17). Female C57BL/6 (CD45.2
 
 
 
) and B6.SJL-Pt-
prca Pep3b/BoyJ (CD45.2
 
 
 
) mice were purchased from The
Jackson Laboratory. Mice (6–12 wk) were anesthetized by i.p. in-
jection with 2,2,2 tribromoethanol and infected intranasally with
250 50% egg infectious doses (EID
 
50
 
) of Sendai virus or 300
EID
 
50
 
 of x31 influenza virus for primary infections and with
3,000 EID
 
50
 
 of PR8 for secondary infections.
 
Cell Lines and Culture Conditions.
 
JAWS II, an immature
dendritic cell line (American Type Culture Collection CLR-
11904), was grown in media containing 5 ng/ml rmGM-CSF.
AM11 cells, a retrovirally transformed B6 alveolar macrophage
line provided by Dr. Bill Walker (St. Jude’s Children’s Research
Hospital, Memphis, TN) were grown as described previously
(18). The T cell thymoma (EL4) and L929/D
 
b
 
 cells were grown
as described previously (19). L cells transected with the D
 
b
 
 MHC
genes have been described previously (20). The BWZ.36 fusion
partner (21) was a gift of Dr. Nilabh Shastri (University of Cali-
fornia, Berkeley, CA). For in vitro infections, the cells were in-
fected with influenza virus, then irradiated at 3,000 rads.
 
Tissue Preparation.
 
Lymphocytes were collected from the
broncho-alveolar lavage (BAL), spleens, lung, and mediastinal
lymph nodes (MLNs)
 
*
 
 as described previously (3). Dendritic cells
 
and macrophages were isolated from 5 mm pieces of lungs and
spleens that were incubated with 5 ml of a 5 mg/ml stock of Col-
lagenase D (Roche). After digestion, the cells were washed and
depleted of erythrocytes. For the isolation of epithelial cells, the
lungs were digested and the B and T lymphocytes were removed
by panning on goat anti–rat IgG coated flasks followed by com-
plement-mediated cytotoxicity (22–24).
 
MHC Tetramer Reagents and Analysis.
 
MHC class I peptide
tetramers specific for NP
 
366–374
 
/D
 
b
 
 and PA
 
224–233
 
/D
 
b
 
 were gener-
ated by the Molecular Biology Core Facility at the Trudeau Insti-
tute as described previously (25). Tetramer staining was per-
formed for 1 h at room temperature, followed by incubation with
anti-CD8-PerCP, and 200,000 events were collected on a Bec-
ton Dickinson FACSCalibur™ flow cytometer. Data was ana-
lyzed using FlowJo (TreeStar) software.
 
Cell Sorting and Adoptive Transfer.
 
For isolation of dendritic
cells and macrophages, cells were stained with anti-CD45R-Cy-
Chrome (B220), anti-CD11c-FITC, and anti-CD11b-PE. Sam-
ples were then sorted on a FACSVantage™ flow cytometer with
DiVa options into B220
 
 
 
CD11b
 
 
 
CD11c
 
 
 
 (predominantly mac-
rophages) and B220
 
 
 
CD11b
 
 
 
/
 
 
 
CD11c
 
 
 
 (predominantly den-
dritic cell) populations. For isolation of memory cells, spleen cells
were stained with anti-CD8-PE and anti-CD44-FITC and sorted
into a purified CD8
 
 
 
CD44
 
 
 
 (memory) population. The purity
after sorting was 95% or greater. Isolated dendritic cells and mac-
rophages were used in an antigen presentation assay and purified
memory cells (2.3 
 
 
 
 10
 
5
 
) were injected i.v. into naive B6.SJL-Pt-
prca Pep3b/BoyJ mice.
 
Generation of LacZ-inducible T Cell Hybridomas.
 
Splenocytes
were harvested from C57BL/6 mice 28 d after intranasal chal-
lenge with A/HK-x31. 30 
 
 
 
 10
 
6
 
 immune splenocytes were cul-
tured with 30 
 
 
 
 10
 
6
 
 irradiated (3,000 rad) peptide pulsed (1 
 
 
 
M
specific peptide) syngeneic splenocytes for 5 d. Blast cells were
enriched by Ficoll and then fused with BWZ.36 cells (26, 27).
Resulting hybrids were stained for TCR
 
 
 
 expression and TCR-
 
 
 
hi
 
 hybrids were cloned by single cell sorting using a MoFlo (Da-
koCytomation). The resulting clones were tested for specificity
using peptide-pulsed L cells transected with the D
 
b
 
 MHC genes.
Influenza virus peptides (NP
 
366–374
 
, PA
 
224–233
 
, PB1
 
703–711
 
, and
HA
 
192–207
 
) were purchased from New England Peptide Inc. and
peptide purity was evaluated using reverse-phase HPLC analysis.
 
Antigen Presentation Assays.
 
Antigen presentation assays were
performed as described previously (21, 27–29). Briefly, hybrid-
omas (10
 
5
 
) were cultured with virus-infected or peptide-pulsed
cells in flat-bottomed microtiter plates. The plates were incubated
overnight, washed with PBS and fixed with 
 
 
 
-galactosidase fixa-
tive (2% formaldehyde/0.2% glutaraldehyde). Cells were washed
again with PBS followed by the addition of 50 
 
 
 
l of a 1 mg/ml
X-gal solution (5 mM potassium ferrocyanide, 5 mM potassium
ferricyanide, and 2 mM magnesium chloride). After 4 h, the hy-
bridomas were examined under a light microscope for the pres-
ence of blue cells.
 
Bone Marrow–derived Dendritic Cells.
 
Bone marrow was
flushed from the legs of C57BL/6 mice, depleted of erythrocytes,
and 2 
 
 
 
 10
 
6
 
 lymphocytes were placed into a bacteriological Petri
dish with media supplemented with 20 ng/ml recombinant mu-
rine granulocyte/monocyte colony-stimulating factor (rmGM-
CSF; PeproTech) and incubated at 37
 
 
 
C with 10% CO
 
2
 
 (30). On
day 3, an additional 10 ml of CTM containing 20 ng/ml rmGM-
CSF was added. On days 6 and 8, half of the cells were removed,
centrifuged, and added back to the same plate in 10 ml of fresh
media containing 20 ng/ml rmGM-CSF. On day 10 of the cul-
ture, the cells were used either in antigen presentation assays or
 
*
 
Abbreviations used in this paper:
 
 EID
 
50
 
, 50% egg infectious dose; LCMV,
lymphocytic choriomeningitis virus;
 
 
 
MLN, mediastinal lymph nodes,
MOI, multiplicity of infection.T
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for dendritic cell vaccination (30). For vaccination, the cells were
resuspended at 5 
 
 
 
 10
 
6
 
/ml and incubated at 37
 
 
 
C for 3 h with
peptide at a concentration of 50 
 
 
 
g/ml (31). After pulsing, the
dendritic cells were washed and injected i.v. into mice at a final
concentration of 0.5 
 
 
 
 10
 
6
 
 per mouse.
 
Results
 
Changing Patterns of Immunodominance during Influenza Vi-
rus Infection.
 
The CD8
 
 
 
 T cell response to intranasal in-
fluenza virus infection in C57BL/6 mice is predominantly
directed against epitopes derived from the nucleoprotein
and acid polymerase proteins (NP
 
366–374
 
/D
 
b
 
 and PA
 
224–233
 
/
 
D
 
b
 
; 15, 16). Whereas T cells specific for both of these
epitopes are present in equivalent numbers in the lung air-
ways during a primary response, T cells specific for the
NP
 
366–374
 
/D
 
b
 
 epitope dominate a secondary (memory) re-
sponse (15). To further investigate these changing patterns
of immunodominance, we undertook a detailed kinetic
and phenotypic analysis of the NP
 
366–374
 
/D
 
b
 
- and PA
 
224–233
 
/
Db-specific T cell response after primary and secondary
influenza virus infection. As shown in Fig. 1, NP366–374/Db-
and PA224–233/Db-specific T cells were equally represented
in the lung airways and parenchyma throughout the pri-
mary response to x31 infection. In contrast, NP366–374/Db-
specific T cells dominated the secondary (memory) T cell
response to a subsequent PR8 infection, during both the
early and late stages of the secondary response. The domi-
nance of NP366–374/Db-specific T cells could not be attrib-
uted to a higher precursor frequency of memory cells spe-
cific for the NP366–374/Db epitope before the secondary
infection. Indeed, the number of memory cells specific for
each epitope were the same in the lungs, MLN, and spleen
at the time of secondary infection, as determined by tet-
ramer staining and ELISPOT analysis ( 11,000 in the
lungs, 8,000 in the MLN, and 80,000 in the spleen, data
not depicted). Both populations of memory T cells were
also indistinguishable on the basis of phenotype (using the
CD44, CD43, Fas, NKG2, CD62L, CD11a markers), cytolytic
activity, and ability to proliferate in vitro after restimulation
(unpublished data). There were also no functional differ-
ences between NP366–374/Db and PA224–233/Db-specific ef-
fector T cells generated in either the primary or secondary
T cell responses (unpublished data, 15, 16).
Changing Patterns of Immunodominance Are Not Depen-
dent on Virus Strain, Dose, or Prior Infection. To determine
whether the change in T cell dominance during primary
and secondary infections reflected intrinsic differences be-
tween the x31 and PR8 influenza virus strains, we reversed
the order of viral infections (PR8 followed by x31). As
Figure 1. Kinetics of the NP366–374/Db and PA224–233/Db-specific re-
sponses after primary and secondary infection with influenza virus.
C57BL/6 mice (three mice per time point) were infected intranasally
with 300 EID50 x31 on day 0 and given a secondary intranasal infection
with 3,000 EID50 PR8 on day 42 (indicated by arrow). Tissues were re-
moved at the indicated time points and stained with anti-CD8 and
NP366–374/Db- or PA224–233/Db-specific tetramers. Shown are the number
of NP- (closed) and PA- (open) specific T cells. The data shown are one
of two complete kinetic experiments with similar results.
Table I. No. of Tetramer  Cells in the Lung Airways After Influenza Virus Infection
No. of cells (10 4)
Mouse strain 1  infectiona 2  infectionb Day of analysisc NP366–374/Db PA224–233/Db NP/PA ratiod
C57BL/6 x31 – 10 1.27 1.74 0.7
x31 PR8 7 6.27 1.33 4.7
PR8 – 10 4.91 5.70 0.9
PR8 x31 7 3.07 0.76 4.0
C57BL/6 Sendai x31 10 3.6 4.8 0.8
aThe primary infection was 300 EID50 (all viruses) delivered intranasally.
bThe secondary infection was 3,000 EID50 (all viruses) delivered intranasally on day 42 after primary (or day 31 after primary for the Sendai virus
primed group).
cCells were analyzed at the peak of infection (day 10 after primary or day 7 after secondary). 
dThe NP/PA ratio was determined by dividing the absolute number of NP-tetramer positive cells by the number of PA-tetramer positive cells in
the lung airways.T
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shown in Table I, the pattern of NP366–374/Db and PA224–233/
Db immunodominance in C57BL/6 mice was independent
of the strain of virus used. Similar patterns were also ob-
tained when antibody-deficient  MT mice were infected
twice with the same virus (unpublished data).
The changing patterns of immunodominance were also
not due to a nonspecific conditioning of the lung by a prior
infection (32). Thus, the ratio of NP366–374/Db- and PA224–233/
Db-specific T cells after x31 infection in mice that had re-
covered from a heterologous intranasal Sendai virus infec-
tion was similar to that of a primary x31 infection (Table I).
As Sendai virus and influenza virus induce very similar in-
flammatory responses in the lung, this suggests that changes
in lung structure and cellular composition induced by a rel-
atively recent respiratory virus infection do not affect the
immunodominance of the subsequent T cell response to
influenza virus. In addition, the changing patterns of im-
munodominance do not reflect differences in the inoculat-
ing dose of virus. Infection with different virus doses al-
tered the magnitude, but not the composition of the T cell
responses (unpublished data). Rather, the immunodomi-
nance of the T cell response depends simply on whether
the response is primary or secondary in nature.
Differential Expression of NP366–374/Db and PA224–233/Db in
Dendritic and Nondendritic Cells. One mechanism that
could account for changing patterns of immunodominance
is that the NP366–374/Db and PA224–233/Db antigens are dif-
ferentially expressed on distinct cell types during a primary
and secondary influenza virus infection (15, 16, 33). To ad-
dress this question, we generated panels of T cell hybrid-
omas specific for the NP366–374/Db and PA224–233/Db
epitopes that could be used as probes for detecting the pre-
sentation of these epitopes. The hybridomas were gener-
ated by fusion with BWZ.36, which contains the Lac Z re-
porter gene under the control of the NFAT element of the
IL-2 enhancer (21, 27–29). TCR mediated recognition of
the relevant antigen by the hybridoma results in  -galac-
tosidase production, which is detected using an X-gal assay.
The advantage of LacZ hybridomas is that they are inde-
pendent of costimulatory requirements and provide a
highly sensitive readout for assessing antigen presentation
ex vivo.
Fig. 2 shows the specificity and sensitivity of two hy-
bridomas that were selected for further studies. Using these
hybridomas, we analyzed NP366–374/Db- and PA224–233/Db-
presentation on H-2b cell lines that had been infected in
vitro with various doses of either x31 or PR8 influenza vi-
rus. These included EL4 (a C57BL/6 derived T cell thy-
moma), AM11 (a C57BL/6 derived alveolar macrophage
line), and JAWS II (an immature C57BL/6 dendritic cell
line). Uninfected cell lines were used as negative controls.
As shown in Fig. 3, the EL4, AM11, and JAWS II cell lines
all expressed the NP366–374/Db epitope after infection with
various doses of live virus. In contrast, only the JAWS II
dendritic cell line presented the PA224–233/Db epitope to
the hybridoma.
These data suggested that there was an intrinsic differ-
ence in the array of antigens presented by dendritic and
nondendritic cells. However, we first considered and ex-
cluded several alternative explanations for these data. First,
the failure of the nondendritic cell lines to express the
PA224–233/Db epitope did not appear to be due to inefficient
infection of the cells as the NP366–374/Db epitope was
strongly presented by these cell lines. Second, the differ-
ence in antigen presentation was also not hybridoma clone
dependent, as the same results were obtained with several
other NP366–374/Db- and PA224–233/Db-specific hybridomas
(unpublished data). Third, the difference in antigen presen-
tation could not be explained by a fundamental inability of
the nondendritic cell lines to present PA224–233/Db to the
hybridomas or to low levels of class I molecules since both
dendritic and nondendritic cells efficiently presented exog-
enously added PA224–233 peptide (Fig. 2). Fourth, the differ-
ence in antigen presentation was not virus strain specific
nor dose-dependent since virtually identical results were
obtained when the cell lines were infected with different
doses of the PR8 virus (Fig. 3). Fifth, the failure of non-
dendritic cell lines to present the PA224–233/Db epitope did
not simply reflect differences in the kinetics of infection
and antigen presentation (Figs. 4 and 5). Furthermore, we
saw no detectable differences in cell viability after infection
of either the macrophage (AM11) or dendritic (JAWS II)
cell line (unpublished data). Finally, we considered the pos-
sibility that the pattern of NP366–374/Db and PA224–233/Db
epitope expression in immortalized cell lines was not repre-
sentative of cells in vivo. To address this issue, we isolated
peritoneal macrophages, flow cytometrically sorted splenic
B cells, and preparations of lung epithelial cells directly
from mice (22, 23, 34). We also generated dendritic cells
Figure 2. Specificity and sensitivity of Lac Z inducible hybridomas.
Clones 53-A8 and 6291-B8 were screened using L-Db, AM11, or JAWS
II cells incubated overnight with either the NP366–374, PA224–233, PB1703–711,
or HA192–207 peptides at the indicated concentrations. The graphs show
the number of positive Lac Z hybridomas per well (no more than 2,000
spots were counted per well).T
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from the bone marrow of C57BL/6 mice by culturing the
cells according to standard protocols (30, 31). These cells
were then infected with x31 or PR8 in vitro and assayed
for antigen presentation using the hybridomas. As shown in
Fig. 6 (left panels), dendritic cells readily presented both the
NP366–374/Db and PA224–233/Db epitopes suggesting that
PA224–233/Db expression is a general characteristic of this
cell type (it should be noted that the enhanced presentation
of the PA224–233/Db epitope, relative to NP366–374/Db, in
this experiment reflects experimental variation and was not
observed in other experiments). In contrast, peritoneal
macrophages, flow cytometrically sorted splenic B cells,
and lung epithelial cells expressed only the NP366–374/Db
epitope, confirming the patterns of epitope expression seen
using cultured cell lines. Together, these data suggested
that there was an intrinsic difference in antigen handling by
dendritic cells compared with other cell types.
Differential Expression of NP366–374/Db and PA224–233/Db in
Dendritic and Nondendritic Cells in Influenza Virus-infected
Mice. The preceding studies show that in vitro infected
cells differ in their capacity to present PA224–233/Db and
NP366–374/Db epitopes to T cells. To determine whether
this was also true in vivo, we analyzed antigen presentation
by different cell types in influenza virus infected mice using
T cell hybridomas as a read-out. As shown in Fig. 7 A, ex-
pression of the NP366–374/Db and PA224–233/Db epitopes was
Figure 3. Presentation of the NP366–374/Db and
PA224–233/Db epitopes after in vitro infection with
influenza virus. The EL4, AM11, and JAWS II cell
lines were infected with influenza x31 (top panels)
or PR8 (bottom panels) for four hours. The cells
were infected with three doses of influenza virus or
left uninfected: multiplicity of infection (MOI) of 0
(open circle), 2 (closed circle), 10 (open triangle),
or 50 (closed triangle). After infection, the cells
were irradiated and then used in a standard antigen
presentation assay with the 53-A8 (NP366–374/Db)
or 6291-B8 (PA224–233/Db) hybridomas.
Figure 4. Kinetics of antigen presentation after in
vitro infection of the JAWS II cell line. The JAWS II
cell line was infected with influenza (x31) for the times
shown with a MOI of 0 (open circle), 2 (closed circle),
10 (open triangle), or 50 (closed triangle). After infec-
tion, the cells were irradiated and then used in a stan-
dard antigen presentation assay with the 53-A8
(NP366–374/Db) or 6291-B8 (PA224–233/Db) hybridomas.T
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readily detected in both the MLN and BAL on day 6 post
x31 infection (tissues from uninfected mice did not stimu-
late the hybridomas, unpublished data). Extrapolating the
data in Fig. 7 A, we estimate that  1:6,000 cells in the
MLN expressed the PA224–233/Db epitope during a primary
infection. In contrast, the frequency of cells expressing the
NP366–374/Db epitope in the MLN was in the order of 10
times higher. This general difference was observed in mul-
tiple experiments and is consistent with the idea that only a
subset of NP366–374/Db-expressing cells also express the
PA224–233/Db epitope in vivo.
We next analyzed antigen expression during a secondary
infection of x31-immune mice that had been challenged with
the PR8 virus. Again, expression of both the NP366–374/Db
and PA224–233/Db epitopes were readily detected in the lung
and MLN after secondary infection (unpublished data). As in
the primary infection, a higher frequency of cells expressed the
NP366–374/Db epitope (relative to PA224–233/Db) in the MLN.
We have repeated these studies several times and at different
times during the primary and secondary infection with very
similar results. Together, these data show that the reduced T
cell response to the PA224–233/Db epitope during a secondary
influenza virus infection cannot be explained by a simple lack
of PA224–233/Db expression by antigen-presenting cells.
Figure 5. Kinetics of antigen presentation after in
vitro infection of the AM11 cell line. The AM11 cell
line was infected with influenza (x31) for the times
shown with a MOI of 0 (open circle), 2 (closed circle),
10 (open triangle), or 50 (closed triangle). After infec-
tion, the cells were irradiated and then used in a stan-
dard antigen presentation assay with the 53-A8
(NP366–374/Db) or 6291-B8 (PA224–233/Db) hybridomas.
Figure 6. Presentation of the NP366–374/Db and
PA224–233/Db epitopes after in vitro infection with
the x31 strain of influenza virus. Bone marrow–
derived dendritic cells, peritoneal exudate cells
(PECs), B cells, and lung epithelial cells were col-
lected from uninfected mice. The cells were then
infected in vitro with influenza virus (x31, top pan-
els; PR8, bottom panels) at an MOI of 0 (open cir-
cle), 2 (closed circle), 10 (open triangle), or 50
(closed triangle) for 4 h, irradiated, and then used in
a standard antigen presentation assay with the
53-A8 (NP366–374/Db) or 6291-B8 (PA224–233/Db)
hybridomas.T
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The fact that there appeared to be different frequencies
of cells expressing the PA224–233/Db and NP366–374/Db
epitopes in vivo was consistent with the in vitro data sug-
gesting that these antigens might be expressed on different
subsets of cells. Thus, we analyzed the presentation of the
NP366–374/Db and PA224–233/Db epitopes by different cell
subsets after in vivo infection. C57BL/6 mice were intra-
nasally infected with x31 and total lung tissue was isolated
6 d later. The cells were then stained with antibodies
specific for B220, CD11b, and CD11c and then sorted
by flow cytometry into predominantly macrophage (B220 
CD11b CD11c ) and predominantly dendritic cell (B220 
CD11b / CD11c ) populations (Fig. 7 B). Purified cells
were then analyzed for PA224–233/Db and NP366–374/Db ex-
pression using the hybridoma assay. As shown in Fig. 7
B, the B220 CD11b CD11c  cells appeared to exclu-
sively express the NP366–374/Db epitope, whereas the cells
B220 CD11b / CD11c  (predominantly dendritic cells)
expressed both the PA224–233/Db and NP366–374/Db epitopes.
These data were consistent with the in vitro infection stud-
ies and suggest that cell subpopulations differ in their ex-
pression of influenza virus antigens.
Naive and Memory T Cells Differ in Their Capacity to Detect
Antigen Presented by Different Types of Antigen-presenting
Cells. Based on the previous data, we speculated that dif-
ferences in the specificity of the primary and secondary
(memory) T cell responses to influenza virus might be reg-
ulated by differences in the capacity of naive and memory
T cells to detect antigen presented by dendritic versus non-
dendritic cells. For example, naive T cells may respond ex-
clusively to dendritic cells (expressing both the PA224–233/
Db and NP366–374/Db epitopes), whereas memory T cells
may preferentially respond to nondendritic cells (expressing
only the NP366–374/Db epitope). An alternative hypothesis is
that the primary infection induces a fundamental change in
the characteristics, distribution, or numbers of antigen pre-
senting cells and it is this change that affects the specificity
of the secondary (memory) T cell response. To distinguish
these possibilities, we used a transfer model to compare the
specificity of concurrent naive and memory T cell re-
sponses to influenza virus infection in the same animal (33,
35). This approach allowed us to compare naive and mem-
ory T cell responses under conditions that excluded differ-
ences in antigen handling. Thus, 2.5   105 CD44 /CD8 
memory spleen cells (with equivalent numbers of NP366–374/
Db and PA224–233/Db specific T cells, unpublished data)
were sorted from C57BL/6 (CD45.2 ) mice by flow cy-
tometry and transferred into naive congenic (CD45.2 )
mice. 1 d later, the mice were intranasally infected with in-
fluenza virus and host and donor T cells specific for the
NP366–374/Db and PA224–233/Db epitopes were assessed by
tetramer staining on day 10 after infection. As shown in
Fig. 8, equal numbers of host naive (CD45.2 , panel B) T
cells in the lung airways were specific for the NP366–374/Db
and PA224–233/Db epitopes, whereas the majority of donor
memory (CD45.2 , panel A) T cells were specific for the
NP366–374/Db epitope. As these distinct responses occurred
in the same animals, these data rule out the possibility that
changes in the characteristics, distribution, or numbers of
antigen-presenting cells between primary and secondary
infections regulate the specificity of the T cell response.
Rather, the differences reflect the differential capacity of
naive and memory T cells to detect antigen on different
sets of antigen-presenting cells. Taken together these data
indicate that the dominance of the NP366–374/Db response
during a secondary infection is regulated by differential an-
tigen presentation by dendritic and nondendritic cells as
well as the differential capacity of these cell types to activate
naive and memory CD8  T cells.
Figure 7. Ex vivo presentation of the NP366–374/Db and PA224–233/Db
epitopes after infection with influenza virus. Mice were infected intrana-
sally with x31 and cells from the lung airways (closed circle) and MLN
(open triangle) were collected on day 6 after infection. (A) Twofold serial
dilutions of cells were made in flat-bottom, 96-well plates starting at 105
cells/well and a standard antigen presentation assay was performed using
the 53-A8 (NP366–374/Db) or 6291-B8 (PA224–233/Db) Lac Z-inducible hy-
bridomas. (B) Cells from the lung were stained with anti-B220-Cy-
Chrome, anti-CD11c-FITC, and anti-CD11b-PE. The macrophage
(B220 CD11b ) and dendritic cell (B220 CD11c ) populations were
collected using a FACSVantage™ flow cytometer with DiVa options.
Twofold serial dilutions of cells were made in flat-bottom, 96-well plates,
and a standard Lac Z APC assay was performed using the 53-A8
(NP366–374/Db) or 6291-B8 (PA224–233/Db) Lac Z–inducible hybridomas.
Cells from uninfected control mice did not elicit a response following in-
cubation with either the NP366–374/Db or PA224–233/Db hybridomas.T
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Vaccination with Peptide-pulsed Dendritic Cells Results in In-
creased Numbers of PA224–233/Db-specific Cells but Delayed Vi-
ral Clearance. Our data have demonstrated that the PA224–233/
Db epitope is not, or poorly, expressed on virally infected
lung epithelial cells. As T cell interaction with virally
infected epithelial cells is believed to be required for effec-
tive viral control, PA224–233/Db-specific T cells may be inef-
fective at clearing an influenza virus infection (36). Based
on previous vaccination studies (19), we hypothesized that
mice primed with the PA224–233 peptide would mediate a
response to influenza biased toward nonprotective PA224–233/
Db-specific T cells resulting in poor viral clearance. To
test this hypothesis, we vaccinated mice with dendritic cells
pulsed with either the PA224–233 peptide or a control Sendai
virus peptide. 2 wk after dendritic cell vaccination, the
mice were infected with 300 50% egg infectious dose
(EID50) x31 and the number of tetramer positive cells and
viral load was determined on day 10 after infection. As
shown in Fig. 9 A, vaccination with PA224–233 pulsed den-
dritic cells resulted in a significant increase in the frequency
of PA224–233/Db-specific T cells (61.7% in vaccinated versus
13.9% in controls) and a significant reduction in the fre-
quency of NP366–374/Db specific T cells (4.7% in vaccinated
versus 9.1% in controls) in the lung airways. Despite the
fact that PA224–233 peptide vaccinated mice made an en-
hanced PA224–233/Db-specific T cell response to influenza
virus infection, they were less effective at clearing the virus.
Vaccinated mice were still harboring virus at day 10 post
infection whereas control mice had completely cleared vi-
rus at this time (Fig. 9 B). These data indicate that vaccina-
tion with peptide defining epitopes expressed exclusively
on dendritic cells (and not at the site of infection) can have
a negative impact on antiviral immunity.
Figure 8. Simultaneous detection of influenza virus-specific naive and
memory cells. Cells were collected from the spleens of C57BL/6 mice in-
fected 32 d previously with 300 EID50 x31. The cells were made into a
single-cell suspension, enriched for CD8  cells and stained with anti-
CD8-PE and anti-CD44-FITC. The memory cells (CD8 CD44 ) were
collected using a FACSVantage™ flow cytometer with DiVa options.
2.5   105 purified memory cells were then injected into naive PepBoy/J
mice. 1 d after transfer, the recipient mice were infected with 300 EID50
x31. 10 d after infection (11 d after transfer), cells from the lung airways
and spleen were collected and stained with anti-CD8-PerCP, anti-
CD45.2-FITC and anti- NP366–374/Db-APC or anti- PA224–233/Db-APC.
A and B show the percentage of NP366–374/Db- and PA224–233/Db-specific
CD8 cells, respectively, within the donor (CD45.2 ) or host (CD45.2 )
lung airway populations. C shows the average (  standard deviation) per-
cent NP366–374/Db- (solid bars) and PA224–233/Db- (striped bars) specific
CD8 cells in the lung airways or spleen.
Figure 9. Vaccination with the PA224–233 peptide results in delayed vi-
ral clearance after influenza virus challenge. Mice were injected i.v. with
0.5   106 dendritic cells pulsed with either the PA224–233 peptide of influ-
enza or a Sendai virus peptide. As a further control, one group of mice
did not receive any dendritic cells (un-vaccinated). 2 wk after vaccina-
tion, the mice were infected with 300 EID50 x31. 10 d after infection,
cells from the lung airways were collected and stained with anti-CD8-
PerCP, and anti-NP366–374/Db-APC or anti-PA224–233/Db-APC. Panel A
shows the percentage of NP366–374/Db- and PA224–233/Db-specific cells of
total CD8s after infection of the Sendai peptide or PA224–233 peptide vac-
cinated mice. B shows the viral load in the lungs of individual mice on
day 10 after infection.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
407 Crowe et al.
Discussion
We have investigated the mechanisms underlying the
changing contributions of NP366–374/Db- and PA224–233/Db-
specific T cells to the primary and secondary response to
influenza virus infection in C57BL/6 mice (15, 16). The
data show that the dominance of NP366–374/Db-specific T
cells in the secondary response cannot be attributed to the
virus strain, nonspecific conditioning of the lungs after viral
infection, or permanent changes in the characteristics, dis-
tribution, or numbers of antigen presenting cells after the
primary infection. Rather, the specificity of the T cell re-
sponse in this system is regulated by differences in the pre-
sentation of the NP366–374/Db and PA224–233/Db epitopes by
dendritic and nondendritic cells and the capacity of naive
and memory CD8  T cells to be activated by these cells.
Based on these data, we speculate that the change in the
specificity of the T cell response reflects the capacity of
memory T cells (in contrast to naive T cells) to respond to
nondendritic cells (Fig. 10). During a primary infection,
naive T cells can only be activated by dendritic cells (4, 37–
39). As dendritic cells express both the NP366–374/Db and
PA224–233/Db antigens, both NP366–374/Db- and PA224–233/
Db-specific T cell responses are elicited. In contrast, during
a secondary infection, dendritic and nondendritic cells can
activate memory T cells. As there is a preponderance of
nondendritic cells that express only the NP366–374/Db anti-
gen, this results in a competitive bias toward reactivation of
NP366–374/Db-specific memory CD8  T cells. Importantly,
the model predicts that the T cell response to the PA224–233/
Db epitope should be diminished, but not completely ab-
sent from the secondary T cell response since the PA224–233/
Db antigen is still being presented by dendritic cells (Fig.
10). Consistent with this, PA224–233/Db-specific memory T
cells do contribute to the recall response at a reduced level
compared with the NP366–374/Db-specific response (Fig. 1).
The model also predicts that the specificity of the T cell re-
sponse is independent of conditioning or alteration of the
antigen-presenting cell pool by prior infection. In support
of this, both primary and secondary patterns of T cell spec-
ificity were simultaneously induced in a transfer model in
which the host and its antigen presenting cells were naive
with respect to influenza virus infection. Finally, the model
predicts that memory T cell responses to the PA224–233/Db
epitope should be poorly competitive with all epitopes that
are expressed on both dendritic and nondendritic cells
(such as NP366–374/Db). Indeed, recent studies using influ-
enza virus mutants that lack the NP366–374/Db epitope but
contain other class I–restricted epitopes indicate that the
PA224–233/Db-specific responses are not amplified after sec-
ondary viral infection (15, 40). Thus, taken together, the
data indicate that differential antigen presentation by den-
dritic and nondendritic cells and the capacity of the T cells
to perceive the antigens presented by these cells regulate
the patterns of T cell specificity in this system (Fig. 10).
A surprising feature of these studies is the observation
that antigen-specific T cells can be elicited during a pri-
mary response that are potentially unable to recognize anti-
gen at the site of infection. The failure to detect the PA224–233/
Db antigen on infected lung epithelial cells is of particu-
lar interest, as T cell lysis of the epithelial layer is believed
to be required for effective viral control (36). Why might
ineffective cells be generated in an infection? One possibil-
ity is that dendritic cells are simply superior presenting cells
compared with other cell types and that PA224–233/Db pre-
sentation to T cells is just above a threshold in dendritic,
but not nondendritic cells. Enhanced presentation of
epitopes by dendritic cells would normally benefit the re-
sponse by ensuring optimal activation of antigen-specific T
cells. However, a negative consequence might be that
weakly presented epitopes result in the induction of T cells
that are not able to recognize antigen at the site of infec-
tion. The idea that ineffective T cells might be generated
during an influenza virus infection has important implica-
Figure 10. A model of antigen presentation and
T cell responses after influenza virus infection. Af-
ter infection with influenza virus, the NP366–374/Db
epitope is processed and presented by both macro-
phages (M ) and dendritic cells (DC). The PA224–233/
Db epitope, however, is only presented by the den-
dritic cells. During the primary response, the naive
T cells respond only to dendritic cells resulting in an
equivalent NP366–374/Db- and PA224–233/Db-specific
T cell response. After secondary infection, the
memory T cells are able to respond to both macro-
phages and dendritic cells resulting in a predomi-
nance of NP366–374/Db specific T cells.T
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tions for the development of peptide-based vaccines de-
signed to promote cellular immunity. The choice of rele-
vant epitopes is usually made based on data regarding
responses to natural infection. However, some epitopes
identified in this manner might actually be detrimental in
terms of their ability to elicit protective immunity if the
epitope targeted were inadequately expressed at the site of
infection. Indeed, in the current studies, the specific prim-
ing of PA224–233/Db-specific T cells by vaccination actually
resulted in impaired clearance of a subsequent influenza vi-
rus infection (Fig. 9). In this situation, we speculate that
primed (memory) PA224–233/Db-specific T cells and naive
NP366–374/Db-specific T cells are both activated by antigen
exclusively expressed on dendritic cells. However, the
higher frequency and higher activation status of the PA224–233/
Db-specific memory T cells resulted in a dominance of
nonprotective PA224–233/Db-specific T cells and concomi-
tant reduction in protective NP366–374/Db-specific T cells
(19). Clearly the selection of appropriate epitopes for vacci-
nation must take into account the pattern of antigen pre-
sentation on different cell types.
A critical question raised by these studies is the frequency
with which differential antigen presentation might affect
the specificity of T cell responses. Several recent studies
suggest that this may be a very frequent occurrence. For
example, Selin et al. (14) have shown that T cells respond-
ing to two major epitopes (LCMV-NP396–404/Db and
LCMV-GP33–43/Db) of lymphocytic choriomeningitis virus
(LCMV) in C57BL/6 mice differentially expand during
primary and secondary infections. Thus, the percentage of
LCMV-GP33–43/Db-specific T cells is significantly increased
in the secondary response (relative to the primary), whereas
the percentage of LCMV-NP396–404/Db-specific T cells re-
mains constant between the primary and secondary re-
sponses. Furthermore, when LCMV infected fibroblasts or
dendritic cells were used to restimulate CTLs, the resulting
CTL lines differentially presented the same epitopes (41).
In addition, following HSV infection the primary CTL re-
sponse to two immunodominant epitopes (gB498–505 and
ICP27445–452) have similar kinetics and precursor frequen-
cies. After reinfection, CTLs specific for the ICP27445–452
epitope are present at higher frequencies than CTLs spe-
cific for the gB498–505 epitope (42).
There are several possible mechanisms that would ex-
plain the differential antigen processing by dendritic and
nondendritic cells after influenza virus infection. One pos-
sibility is that it depends on the degree of infection estab-
lished in the antigen-presenting cells. It has previously
been shown that whereas  90% of both dendritic cells and
macrophages can be infected with influenza virus, the in-
fection in dendritic cells does not result in cell death and
few progeny virions are produced (43, 44). In contrast,
macrophages die within 10–12 h after infection and pro-
duce 10-fold higher progeny than dendritic cells (43).
However, increased levels of virus in macrophages would
tend to favor the processing of both antigens, whereas the
data show that macrophages fail to present detectable levels
of the PA224–233/Db epitope. A related possibility is that the
presentation of the PA224–233/Db antigen may not depend
on viral infection of the antigen presenting cells (45).
However, AM11, JAWS II, and bone marrow–derived
dendritic cells were unable to present the PA224–233/Db or
NP366–374/Db epitopes after administration of high doses of
 -propriolactone inactivated virus (unpublished data, ref-
erence 46). While this indicates that viral infection was
necessary for antigen presentation of these epitopes, it does
not specifically rule out cross-priming as a mechanism for
epitope presentation. Another potential mechanism to ex-
plain the differential processing of the NP366–374/Db and
PA224–233/Db epitopes is that the processing of the PA224–233/
Db epitope depends on immunoproteosomes (47). Thus,
we considered the possibility that the failure of AM11 cells
to present the PA224–233/Db epitope might be reversed
through the induction of immunoproteosomes by IFN- 
(48, 49). However, addition of various doses of recombi-
nant IFN-  had no impact on the patterns of PA224–233/Db
and NP366–374/Db presentation by JAWS II or AM11 (un-
published data) indicating that immunoproteosomes may
not absolutely required for processing the NP366–374/Db
and PA224–233/Db epitopes.
Taken together, the data in this report show that differ-
ential antigen presentation by dendritic and nondendritic T
cells can have a significant impact on the specificity of the T
cell responses. This phenomenon may play a role in deter-
mining immunodominance hierarchies and the efficiency of
T cell responses at effector sites. Additionally, we have
shown that vaccination with an epitope presented predomi-
nantly by infected dendritic cells resulted in delayed control
of a subsequent viral infection. Understanding the impact of
differential antigen processing is therefore essential for the
development of effective peptide-based vaccines.
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